VITIELLO, LIBERO
 Distribuzione geografica
Continente #
NA - Nord America 7.456
AS - Asia 2.911
EU - Europa 2.103
AF - Africa 759
SA - Sud America 651
OC - Oceania 75
Continente sconosciuto - Info sul continente non disponibili 21
Totale 13.976
Nazione #
US - Stati Uniti d'America 7.096
SG - Singapore 1.038
CN - Cina 635
BR - Brasile 444
IT - Italia 361
HK - Hong Kong 333
DE - Germania 285
FI - Finlandia 182
VN - Vietnam 181
SE - Svezia 158
NL - Olanda 120
FR - Francia 97
UA - Ucraina 86
IN - India 84
PL - Polonia 84
GB - Regno Unito 73
RU - Federazione Russa 64
BJ - Benin 43
MX - Messico 40
AT - Austria 37
IE - Irlanda 37
TR - Turchia 34
AR - Argentina 33
ES - Italia 30
IQ - Iraq 30
MU - Mauritius 30
CA - Canada 29
MA - Marocco 29
CI - Costa d'Avorio 28
ZA - Sudafrica 28
AM - Armenia 27
GR - Grecia 27
KE - Kenya 27
UZ - Uzbekistan 27
AE - Emirati Arabi Uniti 26
CH - Svizzera 26
DK - Danimarca 26
EC - Ecuador 26
AL - Albania 25
BE - Belgio 25
IL - Israele 25
JP - Giappone 25
MD - Moldavia 25
PE - Perù 24
TN - Tunisia 24
GH - Ghana 23
GT - Guatemala 23
MK - Macedonia 23
RE - Reunion 23
SA - Arabia Saudita 23
SK - Slovacchia (Repubblica Slovacca) 23
AZ - Azerbaigian 22
BY - Bielorussia 22
CO - Colombia 22
EG - Egitto 22
ID - Indonesia 22
NI - Nicaragua 22
PH - Filippine 22
YT - Mayotte 22
AU - Australia 21
DO - Repubblica Dominicana 21
IS - Islanda 21
PT - Portogallo 21
TJ - Tagikistan 21
AO - Angola 20
KG - Kirghizistan 20
MY - Malesia 20
NP - Nepal 20
PS - Palestinian Territory 20
RS - Serbia 20
SI - Slovenia 20
TT - Trinidad e Tobago 20
BD - Bangladesh 19
CD - Congo 19
CM - Camerun 19
CZ - Repubblica Ceca 19
EE - Estonia 19
KZ - Kazakistan 19
NE - Niger 19
SN - Senegal 19
VE - Venezuela 19
BA - Bosnia-Erzegovina 18
CL - Cile 18
GP - Guadalupe 18
KR - Corea 18
BB - Barbados 17
BO - Bolivia 17
DZ - Algeria 17
GA - Gabon 17
GF - Guiana Francese 17
HR - Croazia 17
IR - Iran 17
KH - Cambogia 17
MG - Madagascar 17
ML - Mali 17
NZ - Nuova Zelanda 17
PY - Paraguay 17
UG - Uganda 17
ZM - Zambia 17
BF - Burkina Faso 16
Totale 13.210
Città #
Fairfield 805
Woodbridge 678
Chandler 635
Ashburn 629
Ann Arbor 625
Singapore 624
Houston 506
Hong Kong 314
Jacksonville 301
Wilmington 295
Seattle 279
Cambridge 263
Santa Clara 224
Beijing 208
Boardman 163
Princeton 144
Dong Ket 99
Padova 89
Roxbury 84
San Diego 76
Los Angeles 74
Medford 71
Munich 70
Helsinki 68
Des Moines 64
Nanjing 57
Bytom 53
Cotonou 43
Chicago 41
São Paulo 41
New York 39
Milan 37
Ho Chi Minh City 31
Dublin 29
Abidjan 27
Buffalo 27
Tashkent 27
Vienna 27
Shenyang 26
Turku 25
Nairobi 23
Baku 22
Managua 21
Rome 21
Yerevan 21
Dushanbe 20
Guangzhou 20
Accra 19
Bishkek 19
Dakar 19
Dallas 19
Luanda 19
Hanoi 18
Hefei 18
Skopje 18
Bamako 17
Falls Church 17
Hebei 17
Jiaxing 17
Kampala 17
Libreville 17
Minsk 17
Nanchang 17
Brooklyn 16
Castries 16
Chennai 16
Guatemala City 16
Phnom Penh 16
Reykjavik 16
Antananarivo 15
Bridgetown 15
Changsha 15
Chisinau 15
Kinshasa 15
Lima 15
London 15
Lusaka 15
Nuremberg 15
Panama City 15
Tallinn 15
Vientiane 15
Dar es Salaam 14
Harare 14
Havana 14
Johannesburg 14
Niamey 14
Podgorica 14
Tunis 14
Warsaw 14
Conakry 13
Djibouti 13
Falkenstein 13
Stockholm 13
Tel Aviv 13
Andorra la Vella 12
Brasília 12
Cayenne 12
Douala 12
Guayaquil 12
Jeddah 12
Totale 8.876
Nome #
A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in the TP63 gene in patients with arrhythmogenic cardiomyopathy 293
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 242
Engineering a 3D in vitro model of human skeletal muscle at the single fiber scale 225
Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients 219
Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation 217
Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization? 208
In vivo delivery of naked antisense oligos in aged mdx mice analysis of dystrophin restoration in skeletal and cardiac muscle 202
Satellite cells delivered by micro-patterned scaffolds: a new strategy for cell transplantation in muscle diseases 197
Secretion-Positive LGI1 Mutations Linked to Lateral Temporal Epilepsy Impair Binding to ADAM22 and ADAM23 Receptors 195
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo 193
Selection of multipotent cells and enhanced muscle reconstruction by myogenic macrophage-secreted factors. 187
A Novel Loss-of-Function LGI1 Mutation Linked to Autosomal Dominant Lateral Temporal Epilepsy 179
A study on duplications of the dystrophin gene: Evidence of a geographical difference in the distribution of breakpoints by intron 177
A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signaling and miRNA dysregulation. 177
Commitment of Autologous Human Multipotent Stem Cells on Biomimetic Poly-L-lactic Acid-Based Scaffolds Is Strongly Influenced by Structure and Concentration of Carbon Nanomaterial 177
Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle 176
A study on duplications of the dystrophin gene: evidence of a geographical difference in the distribution of breakpoints by intron. 168
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 168
Efficient delivery of human single fiber-derived muscle precursor cells via biocompatible scaffold 166
Cardiac involvement in Becker muscular dystrophy 165
Novel Missense Variant in MYL2 Gene Associated with Hypertrophic Cardiomyopathy Showing High Incidence of Restrictive Physiology 163
Gene delivery as a new therapeutic approach 161
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 161
Designing a 3D printed human derived artificial myo-structure for anal sphincter defects in anorectal malformations and adult secondary damage 160
Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization 159
Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma 159
3D Printed Graphene-PLA Scaffolds Promote Cell Alignment and Differentiation 159
A 3' consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions. 154
Low penetrance and effect on protein secretion of LGI1 mutations causing autosomal dominant lateral temporal epilepsy 152
Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma. 151
Electrophysiologic stimulation improves myogenic potential of muscle precursor cells grown in a 3D collagen scaffold 150
A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in mdx Mice 148
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 147
Prevalence of dystrophin-positive fibers in 85 duchenne muscular dystrophy patients 146
Culture of satellite cells in an electrically-stimulated three-dimensional scaffold for the generation of skeletal muscle engineered graft 146
Murine Muscle Precursor Cells survived and integrated in a Cryoinjured Gastroesophageal Junction. 145
DXS997 localized to intron 48 of dystrophin 144
Genomic organization of the human dystrophin gene across the major deletion hot spot & the 3' region 142
Characterization of myogenic factors derived from a stable macrophage cell line 142
Enhancing myoblast proliferation by using myogenic factors: a promising approach for improving fiber regeneration in sport medicine and skeletal muscle diseases 141
In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. 140
Screening for mutations in the muscle promoter region and for exonic deletions in a series of 115 DMD and BMD patients. 140
Dystrophin-positive fibers in duchenne dystrophy: Origin and correlation to clinical course 138
Chronic systemic curcumin administration antagonizes murine sarcopenia and presarcopenia 138
The Rag2–Il2rb–Dmd– mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies 137
Macrophage-secreted factors enhance the in vitro expansion of DMD muscle precursor cells while preserving their myogenic potential 136
A novel nonsense mutation in the human dystrophin gene 136
Biofabricating murine and human myo-substitutes for rapid volumetric muscle loss restoration 136
Reappraisal of the incidence rate of Duchenne and Becker muscular dystrophies on the basis of molecular diagnosis. 130
Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures 130
Muscle tissue engineering using single fibre isolation technique: in vitro and in vivo prospectives 129
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. 129
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 129
ENGINEERING A 3D IN VITRO MODEL OF HUMAN SKELETAL MUSCLE 126
Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: an Age- and Muscle-related Reappraisal 124
Duplication of dystrophin gene and dissimilar clinical phenotype in the same family 123
Physiological electrical stimuli control in vitro satellite cell differentiation 122
Muscle tissue engineering using single fiber isolation technique: in vitro and in vivo perspectives 120
Transfection of cultured myoblasts in high serum concentration with DODAC: DOPE liposomes 120
Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells 119
Immune-Privileged Sites within Skeletal Muscle: Apoptosis of FasL-Transfected Myoblasts Prevents the Formation of FasL-Expressing Muscle Fibers In Vivo 119
Functional differentiation of satellite stem cells by topological and electric stimuli 119
Systemic delivery of therapeutic nucleic acids into skeletal muscle by means of lipid-based vectors 118
Quantitative study of satellite cell differentiation by electrophysiological stimuli 116
Analysis Of Differential Lipofection Efficiency In Primary and Established Myoblasts 116
Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy 116
Detection of unknown gene mutations by multiplex single-strand conformation polymorphism (MSSCP). 114
The LGI1/Epitempin gene encodes two protein isoforms differentially expressed in human brain 114
Comparison of knock-in mouse and hiPSC-based models of arrhythmogenic cardiomyopathy carrying the DSG2 p.Q558* mutation 112
Gene Transfer In Skeletal Muscle By Systemic Injection Of DODAC Lipopoliplexes 112
Three-dimensional porous scaffold allows long-term wild-type cell delivery in dystrophic muscle. 111
La medicina predittiva e il dibattito etico sui test genetici 110
Tuning the Consonance of Microscopic Neuro-Cardiac Interactions Allows the Heart Beats to Play Countless Genres 110
Muscle tissue micro engineering 108
The neuro-cardiac interaction defines an extracellular microdomain required for neurotrophic signaling 105
A report on 528 intragenic deletions detected in DMD and BMD patients by an Italian collaborative study. 104
Recent advances in crispr/cas9-based genome editing tools for cardiac diseases 103
Corrigenda: DXS997 localized to intron 48 of dystrophin (Human Molecular Genetics (1993) 2 (2199)) 102
De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle☆ 102
Characterization of powerful myogenic factors present in media conditioned by murine or human macrophages 99
In vivo tissue engineering of functional skeletal muscle by satellite cells delivered in a photo-polymerizable hydrogel 99
Occurrence of two different intragenic deletions in two male relatives affected with Duchenne muscular dystrophy. 99
Transcriptional analysis of micropatterned muscle cells stimulated 97
Satellite cells delivered by polymer: a new strategy in muscle cell therapy 97
Dystrophin restoration in mdx mice transplanted with wt satellite cells 97
Generation of a human induced pluripotent stem cell line UGENTi002-A from an arrhythmogenic cardiomyopathy patient carrying the c.817C>T DSP heterozygous variant and isogenic control using CRISPR/Cas9 editing 96
Culture of satellite cells in electrical stimulated 3D collagen scaffold for the creation of skeletal-muscle engineered graft 96
Patterns of deletions of the dystrophin gene in different European populations. 96
Heart transcriptome profile of a novel transgenic mouse model for arrhythmogenic cardiomyopathy 94
Gene therapy for muscular dystrophy - Early experiments with liposome-mediated gene transfer 93
Regulatory mutations in transforming growth factor-beta 3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 92
Abstract 4118084: Targeting Monoamine Oxidase B in Dystrophic Hearts Dampens Inflammation and Fibrosis 90
MACROPHAGE-DERIVED MYOGENIC FACTORS AS A TOOL FOR CELL THERAPY IN DYSTROPHIC MUSCLE 87
IN VIVO DELIVERY OF NAKED AND LIPID-COMPLEXED ANTISENSE OLIGOS IN MDX MICE: EFFECTS ON SKELETAL AND CARDIAC MUSCLE 86
Macrophage-secreted factors enhance the in vitro expansion of DMD muscle precursor cells while preserving their myogenic potential 86
The Rag2-/-Il2rb-/-Dmd-/- mouse model: a new kick-off for human myogenic stem cells transplantation 82
Preparation and biological studies of pegylated epirubicin 81
Functionally antagonistic groups of macrophages can be incorporated with human pluripotent stem-cell derived cardiomyocytes to engineer a novel human myocardial infarction model in vitro. 80
Curcumin Administration Improves Force of mdx Dystrophic Diaphragm by Acting on Fiber-Type Composition, Myosin Nitrotyrosination and SERCA1 Protein Levels 78
SNAI1 is upregulated during muscle regeneration and represses FGF21 and ATF3 expression by directly binding their promoters 76
Totale 13.575
Categoria #
all - tutte 44.194
article - articoli 34.878
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 716
Totale 79.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021857 0 0 0 0 109 68 17 105 133 142 138 145
2021/20221.311 27 162 190 72 43 87 66 179 48 13 140 284
2022/20231.209 224 146 28 178 178 156 7 76 145 7 44 20
2023/2024611 19 88 71 47 59 61 40 36 8 35 72 75
2024/20252.567 17 180 107 115 360 77 116 200 247 95 414 639
2025/20264.097 488 745 1.145 1.553 166 0 0 0 0 0 0 0
Totale 14.057